Therapix biosciences ltd. (TRPX)
CashFlow / TTM
Jun'18Jun'17
Net loss

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

0

0

Share-based payment expense

0

0

Finance expenses (incomes), net

0

0

Profit loss

0

0

Working capital adjustments:
Increase in accounts receivable

0

0

Decrease (increase) in trade payables

0

0

Decrease (increase) in other accounts payable

0

0

Working capital

0

0

Net cash used in operating activities

0

0

Cash flows from investing activities:
Increase in restricted cash

-

0

Purchase of equipment

0

0

Grant of convertible loan

0

-

Net cash used in investing activities

0

0

Cash flows from financing activities:
Prepaid public offering costs

0

-

Proceeds from issuance of share capital (net of issuance expenses)

-

0

Net cash provided by (used in) financing activities

0

0

Exchange rate differences on cash and cash equivalents in foreign currency

0

0

Translation differences on cash and cash equivalents

0

0

Increase (decrease) in cash

0

0